Rubella Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
Condition:   Malaria VaccinesInterventions:   Dietary Supplement: Vitamin A;   Biological: Candidate Plasmodium falciparum malaria vaccine;   Biological: MR-Vac;   Biological: StamarilSponsor:   GlaxoSmithKlineNot yet recruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2016 Category: Research Source Type: clinical trials